Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating methenamine plus methylthioninium chloride versus phenazopyridine for symptomatic relief of dysuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine (Methenamine)
  • Methylthioninium chloride (methylthioninium chloride)
  • Phenazopyridine (phenazopyridine)

Snippet

Sponsor: EMS | Conditions: Dysuria | Phase 3 | Status: COMPLETED